You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》匯豐研究下調百濟神州(06160.HK)目標價至186元 評級「買入」
匯豐研究發表評級報告指,百濟神州(06160.HK)次季產品銷量按年升82%至5.54億美元,料強勁銷售勢頭會持續下去,加上公司擁有35億美元現金,料可以支撐其未來兩至三年的營運時間。 該行指,集團美股股價自5月下跌26%,同期納斯達克指數跌10%,相信主要是由於美國藥企艾伯維(AbbVie)對BTK訴訟及旗下自主研發的TIGIT抑制劑遭諾華(Novartis)退貨均拖累股價,但該行認為上述事件對集團收入增長影響有限,銷售勢頭或會持續,並相信市場已消化了TIGIT交易終止帶來的負面因素。 該行提到,料BTK 抑制劑Brukinsa(澤布替尼)海外銷售將加快,下半年PD-1抑制劑Tisle潛在於美國推出。該行估計公司今年、明年及2025年總收入分別達23億美元、29億美元及37億美元。該行將其目標價由196.2元下調至186元,維持評級「買入」。(ca/k) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account